STOCK TITAN

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

Quest Diagnostics (NYSE: DGX) has announced a groundbreaking collaboration with Epic to enhance laboratory testing experiences across the United States. This first-of-its-kind partnership will serve as the foundation for Project Nova, Quest's initiative to improve customer-facing processes.

The implementation will leverage Epic's comprehensive Diagnostic Enterprise system, including Aura, Beaker Laboratory, Care Everywhere, MyChart, and Resolute Professional Billing & Claims across Quest's national laboratory network. The multi-year project aims to streamline account onboarding, lab ordering, results reporting, appointment scheduling, and billing services at Quest's 2,000 patient service centers.

Quest Diagnostics (NYSE: DGX) ha annunciato una collaborazione rivoluzionaria con Epic per migliorare l'esperienza dei test di laboratorio in tutto gli Stati Uniti. Questa partnership unica nel suo genere fungerà da base per Project Nova, l'iniziativa di Quest per ottimizzare i processi rivolti al cliente. L'implementazione sfrutterà il sistema Diagnostico Enterprise di Epic, inclusi Aura, Beaker Laboratory, Care Everywhere, MyChart e Resolute Professional Billing & Claims lungo tutta la rete di laboratori nazionale di Quest. Il progetto pluriennale punta a snellire l'onboarding degli account, gli ordini di laboratorio, la segnalazione dei risultati, la pianificazione degli appuntamenti e i servizi di fatturazione presso i 2.000 centri di assistenza ai pazienti di Quest.
Quest Diagnostics (NYSE: DGX) ha anunciado una colaboración innovadora con Epic para mejorar la experiencia de las pruebas de laboratorio en todo Estados Unidos. Esta asociación sin precedentes servirá como base para Project Nova, la iniciativa de Quest para optimizar los procesos orientados al cliente. La implementación aprovechará el sistema Diagnóstico Empresarial de Epic, que incluye Aura, Beaker Laboratory, Care Everywhere, MyChart y Resolute Professional Billing & Claims en toda la red nacional de laboratorios de Quest. El proyecto plurianual tiene como objetivo agilizar la incorporación de cuentas, los pedidos de laboratorio, la generación de informes de resultados, la programación de citas y los servicios de facturación en los 2.000 centros de atención al paciente.
Quest Diagnostics(NYSE: DGX)가 Epic과의 획기적인 협력을 발표하여 미국 전역의 실험실 검사를 향상시킵니다. 이 최초의 파트너십은 Quest의 고객 지향 프로세스 개선 이니셔티브인 Project Nova의 기초가 될 것입니다. 구현은 Epic의 종합 진단 엔터프라이즈 시스템을 활용하며, Aura, Beaker Laboratory, Care Everywhere, MyChart 및 Resolute Professional Billing & Claims를 Quest의 전국 실험실 네트워크에 걸쳐 포함합니다. 이 다년 간의 프로젝트는 계정 온보딩, 실험실 주문, 결과 보고, 예약 일정 관리 및 청구 서비스를 Quest의 2,000 환자 서비스 센터에서 간소화하는 것을 목표로 합니다.
Quest Diagnostics (NYSE: DGX) a annoncé une collaboration révolutionnaire avec Epic afin d’améliorer les expériences de tests en laboratoire à travers les États‑Unis. Cette partenariat sans précédent servira de base au Project Nova, l’initiative de Quest pour améliorer les processus orientés vers le client. La mise en œuvre s’appuiera sur le système Epic Diagnostic Enterprise, incluant Aura, Beaker Laboratory, Care Everywhere, MyChart et Resolute Professional Billing & Claims à travers le réseau national de laboratoires de Quest. Le projet pluriannuel vise à rationaliser l’intégration des comptes, les commandes de laboratoire, la communication des résultats, la planification des rendez-vous et les services de facturation dans les 2 000 centres de services aux patients de Quest.
Quest Diagnostics (NYSE: DGX) hat eine bahnbrechende Zusammenarbeit mit Epic angekündigt, um die Labortest-Erlebnisse in den Vereinigten Staaten zu verbessern. Diese einzigartige Partnerschaft wird die Grundlage für Project Nova bilden, Quest' Initiative zur Optimierung kundenorientierter Prozesse. Die Implementierung wird das umfassende Diagnostik-Enterprise-System von Epic nutzen, einschließlich Aura, Beaker Laboratory, Care Everywhere, MyChart und Resolute Professional Billing & Claims im gesamten nationalen Labor-Netzwerk von Quest. Das mehrjährige Projekt zielt darauf ab, die Konto-Onboarding-Prozesse, Laboraufträge, Ergebnisberichte, Terminplanung und Abrechnungsdienstleistungen in Quest' 2.000 Patient Service Centers zu straffen.
أعلنت Quest Diagnostics (NYSE: DGX) عن تعاون رائد مع Epic لتحسين تجارب مختبرات الاختبار في جميع أرجاء الولايات المتحدة. ستخدم هذه الشراكة غير المسبوقة كأساس لـProject Nova، مبادرة Quest لتحسين العمليات التي تواجه العملاء. ستستفيد التنفيذ من نظام Diagnostic Enterprise الشامل من Epic، بما في ذلك Aura, Beaker Laboratory, Care Everywhere, MyChart وResolute Professional Billing & Claims عبر شبكة مختبرات Quest الوطنية. يهدف المشروع متعدد السنوات إلى تبسيط إدخال الحسابات، طلبات المختبر، تقارير النتائج، جدولة المواعيد وخدمات الفوترة في 2,000 مركز خدمة للمريض.
Quest Diagnostics(NYSE: DGX)宣布与<Epic开展开创性合作,以提升美国各地的实验室检测体验。这一前所未有的伙伴关系将为<Project Nova打下基础,推动Quest提升面向客户的流程。实施将利用Epic的诊断企业系统,包括Aura、Beaker Laboratory、Care Everywhere、MyChart 以及 Resolute Professional Billing & Claims,覆盖Quest的全国实验室网络。该多年度项目的目标是简化账户注册、实验室下单、结果报告、预约安排和账单服务,覆盖Quest的2,000个患者服务中心
Positive
  • None.
Negative
  • Multi-year implementation timeline suggests extended period before realizing full benefits
  • Complex transition process may temporarily affect existing operations

Insights

Quest's Epic partnership will streamline operations, enhance patient/provider experiences, and create foundation for future innovation including AI.

This collaboration between Quest Diagnostics and Epic represents a significant strategic move in healthcare diagnostics technology integration. Quest's Project Nova initiative, supported by Epic's comprehensive suite including Aura, Beaker Laboratory, Care Everywhere, MyChart, and Resolute Professional Billing & Claims, aims to transform the laboratory testing ecosystem across Quest's entire national network.

The partnership addresses several critical pain points in diagnostic testing workflows. Currently, laboratory ordering, results reporting, and patient interactions often involve fragmented systems that create inefficiencies and frustration for both providers and patients. By consolidating these technologies, Quest will likely achieve operational streamlining that reduces redundancies and improves turnaround times.

Particularly valuable is the implementation of Epic's MyChart for patient-facing improvements. This will provide greater transparency regarding insurance coverage and simplify scheduling at Quest's 2,000 patient service centers. For healthcare systems and independent providers, the standardization of processes should reduce the administrative burden currently associated with laboratory testing.

Beyond immediate benefits, this partnership creates a technological foundation for future innovation. The press release specifically mentions that simplifying systems may accelerate implementation of AI and automation technologies. This forward-looking approach positions Quest to more quickly adopt emerging technologies that could further differentiate their services in the competitive diagnostics market.

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and their patients

SECAUCUS, N.J., Sept. 23, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Epic today announced a first-of-its-kind collaboration designed to streamline and improve experiences for healthcare providers and patients that engage Quest for laboratory testing in the United States.

Epic will work with Quest to deliver a suite of technologies and services to act as the foundation for Project Nova, Quest's multi-year initiative to simplify and enhance several of the company's customer-facing processes to improve experiences, quality and productivity for patients and providers--regardless of the electronic health record (EHR) platform they use. The implementation will be unique with the breadth of Epic's Diagnostic Enterprise system for laboratories--which includes Aura, Beaker Laboratory, Care Everywhere, MyChart, and Resolute Professional Billing & Claims--to be scaled across Quest's national laboratory operation.

"Our collaboration with Epic will raise the bar on what health systems, providers and their patients can expect from their lab experience," said Jim Davis, CEO, Chairman and President, Quest Diagnostics. "Aligning Epic's leading healthcare technologies across our network will help us to optimize insights and experiences for customers and patients while also driving productivity across our enterprise."

"Together, Epic and Quest will make testing easier to navigate for patients while reducing friction for providers and health systems," Sumit Rana, President at Epic, said. "From creation of a single comprehensive test list to a better patient experience with MyChart and more, this is an opportunity to transform the healthcare experience at a national scale." 

The implementation will focus on:

  • Consolidating technologies to improve operational agility, efficiency and quality
  • Streamlining systems ranging from account onboarding, lab ordering and results reporting to patient appointment scheduling, billing and customer service, for greater convenience and ease-of-use for customers
  • Enhancing the patient experience through solutions including MyChart to foster greater transparency in health plan reimbursement and simplify appointment scheduling at Quest's 2,000 patient service centers in the U.S.

Expected customer benefits include faster, more convenient services, access to deeper health and other insights, and faster turnaround times for some testing services. By simplifying systems, the Epic implementation may also allow for faster installment of new innovations, including AI and automation, as new technologies become available.

"The best healthcare companies create innovative solutions that are convenient to access, easy to use and personalized," said Murali Balakumar, Senior Vice President and Chief Information and Digital Officer, Quest Diagnostics. "We are focused on delivering these kinds of solutions across our entire portfolio, leveraging Epic as a foundational technology collaborator, so patients and providers can seamlessly engage with us for their labs and other health insights."

A cross-organization team experienced in large-scale implementations will lead a multi-year phased implementation that prioritizes a seamless transition for health systems, hospitals and other providers.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

Forward Looking Statements
The statements in this press release which are not historical facts may be forward-looking statements.  Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers or strategic partners, acquisitions and other factors discussed in the company's most recently filed Annual Report on Form 10-K and in any of the company's subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the "Business," "Risk Factors," "Cautionary Factors that May Affect Future Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of those reports.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-improve-laboratory-testing-experience-with-industry-first-epic-collaboration-302563549.html

SOURCE Quest Diagnostics

FAQ

What is Quest Diagnostics' Project Nova collaboration with Epic?

Project Nova is Quest's initiative with Epic to streamline laboratory testing experiences through comprehensive integration of Epic's Diagnostic Enterprise system, including features like MyChart, Beaker Laboratory, and billing services across Quest's national network.

How will the Epic collaboration affect Quest Diagnostics (DGX) customers?

Customers will benefit from faster services, improved scheduling at Quest's 2,000 patient service centers, better health insights, faster test turnaround times, and enhanced transparency in health plan reimbursement.

What Epic systems will be implemented at Quest Diagnostics?

Quest will implement Epic's complete Diagnostic Enterprise system, including Aura, Beaker Laboratory, Care Everywhere, MyChart, and Resolute Professional Billing & Claims.

When will Quest Diagnostics complete the Epic implementation?

The implementation will be conducted in phases over multiple years, with a focus on ensuring seamless transition for health systems, hospitals, and providers.

How will this partnership improve Quest Diagnostics' technological capabilities?

The Epic integration will simplify systems, enabling faster implementation of new innovations including AI and automation, while improving operational agility, efficiency, and quality.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

20.73B
111.33M
0.4%
99.16%
3.8%
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS